Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| VIASAT INC | VSAT | 19.35% |
| OLD SECOND B | OSBC | 5.76% |
| GAMCO INVEST | GBL | 4.61% |
| CORNING INC | GLW | 4.47% |
| SYNCHRONOSS | SNCR | 4.23% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
St. Jude Medical ( STJ - Analyst Report ) has received CE Mark approval for two of its devices viz. the AMPLATZER Amulet Left Atrial Appendage Occluder and the ViewFlex Xtra Intracardiac Echocardiography (ICE) Catheter. Both the products were unveiled at the 18th annual Boston AF Symposium.
About AMPLATZER Amulet
The advanced Amulet cardiovascular device from the company’s Cardiovascular and Ablation Technologies Division (CATD) is technically a notch above the original AMPLATZER Cardiac Plug, as it can be used to treat a wider range of appendage anatomies. The percutaneous transcatheter device is intended to seal off left atrial appendage (LAA) in patients ailing from non-valvular atrial fibrillation (AF).
As per the World Health Organization (WHO), strokes occur in approximately 15 million people across the globe every year, rendering it to be one of the leading causes of death and long-term disability. Following the success of the AMPLATZER Cardiac Plug, the Amulet device should further boost structural heart devices sales. However, it has not yet been cleared by the U.S. Food and Drug Administration (FDA). Edwards Lifesciences Corp. ( EW - Analyst Report ) also manufactures transcatheter heart valves and currently carries a Zacks Rank #2 (Buy).
About ViewFlex Xtra
St. Jude’s ViewFlex Xtra ICE Catheter, again from the Cardiovascular and Ablation Technologies Division (earlier AF division), also received the European CE Mark and is already FDA approved. The catheter allows seamless movement during cardiac ablation surgeries, thereby enhancing clinical outcomes.
Along with the ViewMate Z Intracardiac Ultrasound Console, the device provides real-time image guidance and visualization of a patient’s cardiac anatomy and is capable of delivering fast, high-fidelity images, which helps physicians during electrophysiology procedures.
St. Jude forayed into the high-growth ICE market in 2008 with the acquisition of leading electrophysiology products maker EP MedSystems. The medical devices behemoth obtained the ViewFlex ICE catheters and ViewMate II ultrasound imaging system through this acquisition. Medtronics Inc. ( MDT - Analyst Report ) is also expanding its foothold in the emerging AF market.
St. Jude will be reporting its fourth-quarter earnings results on Jan 23 and currently carries a Zacks Rank #3. We also look forward to orthopedic major, Stryker Corp.’s ( SYK - Analyst Report ) results, releasing tomorrow.
Read the full Analyst Report on MDT
Read the full Analyst Report on SYK
Read the full Analyst Report on STJ
Read the full Analyst Report on EW